Most material SEC filings — August 20, 2026

Amylyx Pharmaceuticals conducted a public offering of 14,090,000 firm shares at $35.50 per share (approximately $501M gross proceeds), with underwriters granted an option to purchase up to 2,113,500 additional shares. Lead underwriters are Leerink Partners, Morgan Stanley, Guggenheim Securities, and LifeSci Capital. The offering was priced on August 19, 2026, with first delivery scheduled August 21, 2026. At pricing of $35.50/share, the company raised approximately $501M before underwriting discounts.

Rising Dragon Acquisition Corp. (public market value ~$59.8M) filed an 8-K on August 20, 2026, reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, with a Transfer of Listing. The filing provides no specific details regarding which listing standard was violated, the timeline for remediation, or any specific financial metrics or counterparties involved.

On 2026-08-20, Webster Financial Corp completed an acquisition (Item 2.01), triggering a change in control (Item 5.01), delisting notice (Item 3.01), modification of security holder rights (Item 3.03), and changes in directors/officers (Item 5.02). Specific counterparty name, purchase price, financing terms, share count, and detailed governance changes are not disclosed in this 8-K header filing text alone.

JBS N.V., already a significant shareholder in Pilgrim's Pride Corporation (PPC), submitted a non-binding proposal on August 18, 2026 to acquire all outstanding PPC shares it does not own at a fixed exchange ratio of 2.086 JBS Class A shares per PPC share (implying ~$28.49/PPC share based on JBS closing price of $13.66). JBS stated it will not proceed without approval from a special committee of independent directors, independent advisors, and majority approval from non-JBS shareholders. The proposal is expressly non-binding and conditions-free for JBS, but would consolidate PPC as a subsidiary of the larger Brazilian meat processor.

Eightco Holdings (market cap ~$3.8M) repurchased 14 million shares under its $125M program in the past two weeks. As of August 19, 2026, treasury holds: $90M OpenAI equity (indirect, via SPVs), $18M Beast Industries equity, 16,278 ETH, 302M WLD tokens (~8.4% of circulating supply, largest disclosed institutional position), and $132M cash/stablecoins, totaling ~$389M. Company also participated in World Foundation's $52.5M funding round (led by Pantera, Bain Capital Crypto, others).

BullFrog AI Holdings, Inc. received a notice of delisting or failure to satisfy continued listing requirements on August 18, 2026. The filing is an 8-K Item 3.01 disclosure; specific listing rule violations and remediation timelines are not detailed in the excerpt provided.

Real Brokerage Inc. (NASDAQ: REAX) is acquiring RE/MAX Holdings, Inc. (NYSE: RMAX) in a transaction expected to close August 24, 2026. RE/MAX stockholders elected merger consideration: 18.5M shares chose cash ($13.80/share, capped at $60–$80M total), resulting in proration to ~$4.33 cash + ~0.3535 Real shares per RE/MAX share; remaining shareholders receive ~0.5150 Real shares per share (post-10-for-1 consolidation). Real will consolidate its shares 10-for-1 effective August 24, 2026.

T3 Defense Inc. filed an 8-K on August 20, 2026, reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, with potential transfer of listing. The filing does not specify which exchange, the exact reason for non-compliance, or remediation timeline, but indicates the company has failed to meet continued listing standards.

On August 18, 2026, InnSuites Hospitality Trust (market cap ~$3.7M) entered into a material definitive agreement and conducted an unregistered sale of equity securities. Specific dollar amounts, share counts, counterparty names, and transaction terms are not disclosed in this 8-K filing summary; the actual agreements are referenced in exhibits but their contents are not provided in the accessible text.

Aptera Motors announced a strategic investment partnership with Launch Design (Shanghai Launch Automotive Technology Co., Ltd.) valued at approximately $44 million (RMB 300 million) covering assembly fixtures, tooling, vehicle testing, pilot production, and high-volume manufacturing. Aptera will pay two-thirds of approved costs (~$29.3M) in cash, with Launch paying the remaining one-third (~$14.7M) in warrants. The partnership targets production of Aptera's first 40 vehicles in Q4 2026 and provides access to Launch's international supplier network for finished subassemblies at reduced costs.

Bleichroeder Acquisition Corp. II (SPAC, ~$291M assets) will hold a shareholder vote on August 25, 2026 to approve its proposed business combination with Pasqal Holding SAS, a French quantum-computing company. The Form F-4 registration statement was declared effective by the SEC on August 5, 2026. Pasqal has raised >$300M in funding, employs ~300 people, and serves 25+ clients including Saudi Aramco, LG Electronics, and IBM (Quantum Network partner).

Splash Beverage Group reported a 64% reduction in loss from continuing operations for H1 2026 ($4M vs. $11M prior year) through cost-cutting. Post-quarter (July–August 2026), the company executed a strategic transformation: acquired exclusive global license for CannEpil (pharmaceutical-grade cannabinoid for epilepsy and veterinary applications), entered collaboration with Lupvindol Biosciences for FDA veterinary drug development, initiated UK/Ireland/Latin America commercialization, and rebranded to Endovia Health Sciences effective August 24, 2026. No financing amounts, licensing fees, or equity dilution disclosed.

Newton Golf Company entered into a Securities Purchase Agreement to raise up to $5,000,000 through a private placement of common stock in one or more tranches (minimum first tranche $1M). The per-share price is the greater of $0.01 above the prior day's close or 5-day average close, with a floor of $1.24/share. Investors receive registration rights to resell shares via Form S-1 or S-3 shelf registration within 45 days of closing.

Flux Power Holdings' 10-K (fiscal year ended June 30, 2026) discloses authorized capitalization of 75M common shares and 3M preferred shares, including 1M Series A Convertible Preferred shares with 8% cumulative dividends, senior liquidation rights, and conversion features. The independent auditor (Haskell White LLP) expressed substantial doubt about the company's ability to continue as a going concern in their August 20, 2026 report. No specific dollar amounts, new financing terms, or recent material transactions are disclosed in this excerpt.

On August 20, 2026, Splash Beverage (market cap ~$6.5M) filed S-1/A to register resale of 5,000,000 common shares by C/M Capital Master Fund, LP under an equity line of credit (ELOC) agreement dated September 19, 2025. The company may receive up to $30,782,793 in gross proceeds (remaining capacity of $35M total commitment less $4.2M already drawn). Simultaneously, Splash abandoned its failed beverage business, licensed CannEpil (CBD/THC pharmaceutical for epilepsy) worldwide for $5.5M in preferred stock issued July 6, 2026, and executed a veterinary collaboration agreement worth up to $1.11M in milestone payments. The company is in critical condition: going-concern warning, NYSE compliance deadline January 29, 2027, negative stockholders' equity of ($15.3M), trading at $0.41/share post-1:4 reverse split, only 3 full-time employees, and $2M cash burn projected for next 12 months.

10% owner CASCADE INVESTMENT, L.L.C. (RSG) bought 379K shares (~$83.4M) on the open market (0.3% of holdings). Open-market insider purchase — historically a bullish signal.

LivePerson adjourned its special stockholder meeting from August 20, 2026 to September 2, 2026 to allow more shareholders to vote on the proposed merger with SoundHound AI. As of the adjournment date, 97% of votes cast favored the merger, but the transaction requires approval from a majority of all outstanding shares—a threshold the company stated it was only a few percentage points away from reaching. No merger terms, valuation, or deal economics were disclosed in this filing.

Form 8-K filed 2026-08-20 reports Item 5.01 (Changes in Control of Registrant) and Item 8.01 (Other Events). The filing header and metadata are present, but the actual narrative disclosures describing the counterparty, transaction terms, dollar amounts, timing, and nature of the control change are not included in the text provided. Without access to the full 8-K document body, specific details cannot be confirmed.

Director WARREN KELCY L (ET) bought 1.0M shares (~$21.3M) on the open market (0.7% of holdings). Open-market insider purchase — historically a bullish signal.

Cantor Equity Partners I, Inc. (SPAC) terminated its July 2025 Business Combination Agreement with BSTR Holdings and related entities on August 20, 2026. The Seller (BSTR Holdings Cayman) or Blockstream Capital Partners must pay the SPAC $15M in two installments: $10M on September 19, 2026, and $5M on December 1, 2026. All parties executed mutual releases and covenants not to sue regarding the terminated transaction and ancillary agreements.

Callan JMB Inc. (Nevada corp, $7.4M market cap) amended its July 2025 purchase agreement with Hexstone Management LLC, increasing the available commitment from $25M to $75M in Common Stock issuances. The investor can direct purchases of $0.5M–$2M at 90–95% of recent trading prices, with monthly sales limited to $25K/day or 20% of daily volume. The company must register resale shares and pay transaction expenses (capped $50K). Termination fee of $250K due if company terminates before selling $7.5M. Agreement expires April 1, 2027.

Odysight.ai priced a public offering of 3,437,500 common shares at $3.20 per share for $11M gross proceeds (approximately $9.5M net after underwriting fees, estimated ~13-15% discount). The company granted Roth Capital Partners a 30-day option to purchase an additional 515,625 shares (15% overallotment). Directors Benad Goldwasser and Mori Arkin participated alongside existing shareholders. Proceeds designated for R&D, sales/marketing, and working capital; offering expected to close August 21, 2026.

Fortitude Mining purchased 411,522 shares of HeartSciences common stock on August 12, 2026 for $1.0 million ($2.43/share, a 22% premium to prior close), giving Fortitude ~9.4% ownership. The investment supports HeartSciences' operating expenses pending the expected H2 2026 close of their proposed business combination; Fortitude will not receive additional merger consideration as a result of this subscription.

As of July 31, 2026, PowerCompute held 315.1 BTC valued at ~$20.2M (since risen to $21.5M by August 19). The company mined 7.9 BTC in July (down from 8.7 in June due to seasonal curtailment) and sold 11.1 BTC, while capturing $91,000 in energy sales revenue. In August, PowerCompute refinanced and consolidated ~$18M in debt into a single facility with Arch Lending secured by Bitcoin collateral, allowing the company to avoid selling holdings to service debt.

NN Inc, a $74.4M market-cap precision components manufacturer, raised full-year 2026 guidance twice: net sales from $450–470M to $460–480M (midpoint $470M, +10% YoY); adjusted EBITDA from $52–62M to $55–65M (midpoint $60M, +22% YoY); new business wins from $80–90M to $80–100M (midpoint $90M, +29% YoY). Q2 2026 results showed +19% net sales growth YoY ($128.7M vs. $107.9M Q2'25) and +36% adjusted EBITDA growth ($17.9M vs. $13.2M). Company is pivoting from legacy auto (65% of 2023 sales) to growth markets—data center/electric grid ($80M TTM, $120M target), defense/electronics ($60M TTM, $90M target), medical ($15M TTM, $40M target)—with $15M in AI data center awards in 2026 YTD and $12–15M firearms accessories contract ramping Q3 2026.

LSI Industries acquired Royston Group on March 24, 2026, contributing $66.9M in Q4 sales. Full-year FY2026 net sales increased 20% to $689.4M (record); adjusted net income rose 28% to $42.2M, with adjusted EPS of $1.25 vs. $1.07 prior year. Net debt to proforma TTM Adjusted EBITDA rose to 2.7x from 0.82x (prior year), reflecting acquisition financing. Declared quarterly dividend of $0.05/share.

On August 14, 2026, Ocean Power Technologies received notice from NYSE American that it failed to timely file its Form 10-K for the year ended April 30, 2026, which was due August 13, 2026. The company cured the non-compliance on August 19, 2026, by filing the 10-K with the SEC, regaining compliance within the six-month cure period ending February 13, 2027. No financial penalties or delisting action occurred, and no specific operational, financial, or strategic details about the company's performance were disclosed in this filing.

NexGel filed an S-1 on August 20, 2026 to register resale of 15,252,337 common shares issuable upon conversion of convertible promissory notes totaling ~$11.4M issued April–May 2026 and in connection with the April 2026 Celularity acquisition. Notes convert at $0.60/share (subject to full-ratchet anti-dilution and automatic downward resets) and bear 10% interest. Company had $0.5M cash and $4.5M net loss for H1 2026, with substantial doubt about going-concern status. Registration covers only note conversions; warrant shares (5.8M+) not registered due to authorized share shortage. Stockholders rejected a 100M-share authorization in July 2026; a September 23, 2026 vote on 150M authorization is pending.

Flux Power (NASDAQ: FLUX) reported fiscal 2026 revenue of $42.1M (down 37% from $66.4M in FY2025) and a net loss of $7.4M ($0.38/share) on 19.8M weighted average shares. Q4 FY2026 revenue was $8.2M, operating expenses fell 33% YoY to $4.4M in Q4, and cash declined to $305K from $1.3M YoY. The company appointed Stu Jacover as VP Sales, launched SkyEMS 3.0 software, and achieved new OEM certification. Adjusted EBITDA was negative $4.5M for the full year (vs. negative $0.1M in FY2025); line of credit stands at $6.3M.

Scienture Holdings (market cap ~$10.2M) reported Q2 2026 revenue of $343,639 (vs. $56,325 in Q1 2026, a 510% sequential jump) and H1 2026 revenue of $399,964 (vs. $10,258 in H1 2025). Q2 2026 gross margin was 97.7% on gross profit of $335,779. Operating loss improved 48% YoY to $2.7M; net loss narrowed 58% YoY to $2.8M. Cash increased to $11.2M (including $3M restricted) from $6.7M at year-end 2025. The company commenced commercial launch of REZENOPY (naloxone nasal spray) in Q3 2026, its second FDA-approved product alongside ARBLI (losartan suspension), and secured formulary coverage with a major national health plan.

Edesa Biotech (NASDAQ-listed, ~$14M market cap) completed an underwritten public offering on August 21, 2026, issuing 3,870,500 common shares at $5.50/share plus warrants, 675,000 pre-funded warrants at $5.4999, and warrants to purchase 4,545,500 common shares at $7.50 exercise price. Guggenheim Securities was sole underwriter. Gross proceeds ~$21.3M before expenses. Company granted 90-day lock-up on insiders and agreed to pay 6% solicitation fee to underwriter on warrant exercises.

NexPoint Real Estate Finance amended its loan agreement with Mizuho Capital Markets LLC, effective August 17, 2026. The Term Loan Amount is set at $450M. Prepayment terms were modified: borrower must prepay 100% of underlying investment repayments until outstanding balance falls below $384M, then 75% until $300M, then 50% thereafter (versus prior terms). The company also amended the security agreement and updated counsel contact information from Winston Strawn to Paul Hastings.

Better Home Finance Holding Company's Special Committee adopted a limited-duration shareholder rights plan effective August 20, 2026, expiring at the 2027 Annual Meeting. The plan distributes one Class A/B/C Right per corresponding share class (record date August 31, 2026) with a 15% beneficial ownership threshold trigger. Rights become exercisable allowing shareholders (except triggering party) to purchase additional common shares at substantial discount. Plan targets former CEO Vishal Garg's effort to gain control via super-voting shares without proper disclosure or premium.

Virtuix reported Q1 FY2027 (ended June 30, 2026) with new Omni One orders up 72% year-over-year and ~150% since the Meta Quest launch. Revenue declined 26% to $0.8M (from $1.0M prior year) due to completion of legacy backlog, but gross margin expanded to 30% from 17%. Net loss widened to $7.2M from $2.3M, driven by $4.0M in non-cash charges (primarily $2.5M interest expense/debt discount amortization on convertible notes). Cash fell to $7.4M from $9.5M; stockholders' equity swung to a $3.1M deficit. Key wins: U.S. Marine Corps Infantry Fireteam Trainer pilot delivery expected Q4 2026; first Omni One Enterprise sale to Tesla Optimus; NASA Moon/Mars Analog mission selection; Sirica Therapeutics autism therapy partnership (targeting ~100 treatment centers). Company pursuing defense M&A targets with $10M–$50M revenue.

On April 28, 2026, BayFirst Financial Corp. raised $80M via private placement of 4,000 Series D Preferred Stock shares ($40M) and 4,000 Series E Preferred Stock shares ($40M) at $10,000/share from accredited investors including Kenneth R. Lehman (principal investor). On July 14, 2026, all 8,000 preferred shares automatically converted into 22,856,000 common shares. This S-1/A registers those 22.9M shares for resale by selling shareholders; BayFirst receives no proceeds. Kenneth Lehman holds 11.4M shares (42.4% post-conversion), with contractual board designation rights and gross-up anti-dilution provisions.

BayFirst Financial Corp. (market cap ~$49.3M) is conducting a rights offering to raise up to ~$14.4M by issuing up to 4,108,072 common shares at $3.50/share to shareholders of record as of May 12, 2026. This follows an April 28, 2026 private placement of $80M in convertible preferred stock (Series D & E) at the same $3.50 effective conversion price to Kenneth Lehman and others. Lehman received board designation rights and gross-up rights; the company redeemed $9.7M of Series A/B preferred on August 6, 2026. Proceeds target capital levels, loan loss reserves, and return to profitability.

Energy Vault Holdings subsidiary EV Gen Set 1, LLC executed a credit agreement dated August 14, 2026 with CSC Delaware Trust Company as agent. The facility provides $137.5M in Delayed Draw Term Commitments available through December 31, 2027 on a declining monthly draw schedule. Proceeds fund equipment purchases under an Equipment Supply Agreement with interest rates of 6.75–7.50% (SOFR loans) or 5.75–6.50% (ABR loans), plus 1% annual commitment fee. Maturity is January 2, 2028. Key conditions include equity funding requirements, Debt Service Reserve Account maintenance, and collateral perfection.

Icahn Enterprises completed the sale of Pep Boys (approximately 800 locations) to Mavis Tire Express Services Corp. for $700 million in cash on August 20, 2026. IEP retained owned real estate, AAMCO Transmissions, and Precision Tune Auto Care businesses from the transaction. The sale represents a significant divestiture of a major operating asset from IEP's automotive segment.

Eva Live Inc. replaced its May 2025 employment agreement with David Boulette (CEO) effective August 17, 2026. New terms: $800k base salary increasing 10% annually to $1.17M by Year 5; up to 800k Series A Preferred shares (convertible 150:1 to common) earnable upon Nasdaq uplisting (already achieved Jan 2026—200k shares), Year 2 acquisition/product milestone ($5M+ threshold—200k shares), and Years 3–5 annual 30% sales growth targets (200k shares each). Termination without cause triggers $5M lump sum plus pro-rata bonus and 6 months COBRA reimbursement. Board authorized issuance of 1M Series A Preferred shares with liquidation preference, conversion rights, and majority-holder voting protection on anti-dilution matters.

American Battery Technology Company (NASDAQ: ABAT) announced Q4 FY2026 (ended June 30, 2026) unaudited results: revenue $8.2M (up 5.1% QoQ), gross profit $1.3M (up 86% QoQ), and zero debt with $50.3M cash. Most significantly, the company successfully appealed a DOE termination and secured reinstatement of a $57M competitive grant supporting the $115M construction of its Tonopah Flats Lithium Project (TFLP) first processing train. However, a new federal directive effective August 27, 2026, requires 100% allocation of black mass sales to U.S. persons—a material risk since substantially all current black mass customers are foreign OECD entities and black mass represents majority of current revenue.

Cosmos Health (market cap ~$9.5M) reported Q2 2026 revenue of $19.0M (+28.8% YoY) and H1 revenue of $36.9M (+29.7% YoY), reaching an annualized run-rate exceeding $75M. The company reduced total liabilities by $6.27M (13.3%), increased stockholders' equity 12.2% to $20.67M, and authorized a $5M share repurchase program (5.1M shares repurchased for ~$1.11M as of filing date). However, GAAP net loss widened to ($6.09M) in Q2 due to $2.65M in non-cash fair-value adjustments on financing arrangements, while adjusted EBITDA remained negative at ($1.13M).

Santander Holdings USA, Inc. (SHUSA) completed its acquisition of Webster Financial Corporation on August 20, 2026, creating a combined entity with ~$327B in assets, $185B in loans, and $172B in deposits (pro forma as of Dec 31, 2025). The transaction involved Webster Financial merging into Webster Virginia Corporation, which then contributed its shares to SHUSA, followed by Webster Virginia merging into SHUSA. Webster becomes part of Santander Bank, N.A.; Santander's customer base expands to ~8 million; combined company targets ~18% return on tangible equity by 2028.

Director Apeiron Investment Group Ltd. (ENHA) bought 6.0M shares (~$2.9M) on the open market (54% of holdings). Open-market insider purchase — historically a bullish signal.

ASP Isotopes' subsidiary Renergen (via Tetra4) has commenced commissioning Phase 1 of a liquid helium plant at the Virginia Gas Project in South Africa. Phase 1 is expected to produce ~70 Mcf/day of liquid helium and ~2,500 GJ/day of LNG, with first commercial helium shipments expected September 2026 and ramp to nameplate capacity in H2 2026. Assuming $600/Mcf helium pricing and $15–18/GJ LNG, Phase 1 alone should generate ~$27M annualized revenues; Phase 2 (13× larger, ~44-month construction starting H2 2026) is planned to be funded by up to $750M debt (IIFC $500M, Standard Bank $250M). Currently 75% of Phase 1 LNG and 15% of Phase 1 helium are under take-or-pay contracts.

Brandon Torres Declet resigned as CEO and Chairman effective August 19, 2026. Ben Williams, COO since 2019 and former interim CEO (June–November 2023), was appointed Interim CEO; Gregory McNeal, an independent director and Defense Advisory Board chair, became Chairman. Both are military veterans. The company reported Q2 2026 revenue of $950K (down from $1.4M YoY), gross margin of 46.9% (up 630 bps), net loss of $6.9M ($1.55/share vs. $2.22/share YoY), and cash of $7.8M (vs. $812K at year-end 2025, boosted by May 2026 IPO proceeds). Leadership change follows disclosure in amended Form 10-Q of an Audit Committee internal investigation and material weaknesses in internal controls.

10% owner PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD. (SUJA) bought 568K shares (~$4.1M) on the open market (5.5% of holdings). Open-market insider purchase — historically a bullish signal.

President and CEO Young Richard Scott (IAUX) bought 1.0M shares (~$1.6M) on the open market (14% of holdings). Open-market insider purchase — historically a bullish signal.

Director Courtis Kenneth S. (AMR) bought 15K shares (~$2.9M) on the open market (1.5% of holdings). Open-market insider purchase — historically a bullish signal.

Jack in the Box appointed Taylor Montgomery (former Global Chief Brand Officer at Taco Bell/Yum! Brands) as President effective September 14, 2026, in a newly created role. Montgomery will lead brand strategy and is expected to become CEO within 12 months. His offer letter specifies: $700,000 base salary, $220,000 signing bonus (earned through October 1, 2027), $1.5M inducement RSU grant (vesting over 3 years), 75% annual bonus target, and future $500K-$1M annual LTI grants. This represents execution of the company's previously announced succession plan.

Twin Disc reported fiscal 2026 net sales of $381.3M (up 11.9% YoY) and net income of $27.1M versus a loss of $0.7M in FY2025. The company achieved EBITDA of $29.9M, free cash flow of $9.2M, and a six-month backlog of $178.3M. A significant accounting change from LIFO to FIFO inventory method increased prior-year inventory by $32.1M. The company also secured a new $90M credit facility with BMO and JP Morgan.